EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex

Jahnavi Dharwadkar iD, Amrutha R Nayak iD, B S Shankaranarayana Rao iD, Bettadapura N Srikumar iD

Annals of Neurosciences · 02.08.2026

DOI: 10.1177/09727531261448654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurosciences, online erschienen am 02.08.2026. Verfasst von Jahnavi Dharwadkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression is a pervasive mental health disorder that has been extensively studied, but effective treatment remains elusive. This is due to the lack of understanding regarding the underlying molecular mechanisms. Antidepressants usually target the monoaminergic system, but studies show that other neurotransmitters, such as acetylcholine (ACh), may be involved. Many clinical and preclinical studies show that increased ACh levels are associated with depression. Particularly, acetylcholinesterase (AChE) activity is shown to decrease in depression and antidepressants are known to increase it. However, it is not known whether this effect is direct or downstream.

Purpose

To check whether antidepressants can directly modulate AChE activity, we evaluated the effect of various classes of antidepressants on ex vivo AChE activity in the frontal cortex, hippocampus and striatum of male and female rats.

Methods

Briefly, sertraline (SER), escitalopram (ESC), amitriptyline (AT), duloxetine (DUL), bupropion (BUP) and ketamine (KET) were incubated with the brain tissue homogenates in a 96-well plate for 30 min, following which AChE activity was evaluated by modified Ellman’s method.

Results

SER and ESC increased AChE activity in the frontal cortex, while AT, DUL, BUP and KET did not affect it.

Conclusion

This points to a novel mechanism of action of selective serotonin reuptake inhibitors (SSRIs) and a potential target for developing new therapeutics with better efficacy and lower side effect profiles.

Schlagwörter

Stichwörter der Autor:innen

Escitalopramacetylcholineduloxetinefrontal cortexhippocampusketamine

Autor:innen und Institutionen

  • Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India.
  • Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.

ORCID-Profile: Jahnavi Dharwadkar, Amrutha R Nayak, B S Shankaranarayana Rao, Bettadapura N Srikumar

Zitieren

APA

Dharwadkar, J., Nayak, A. R., Rao, B. S. S., & Srikumar, B. N. (2026). Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex. Annals of Neurosciences. https://doi.org/10.1177/09727531261448654

Vancouver

Dharwadkar J, Nayak AR, Rao BSS, Srikumar BN. Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex. Annals of Neurosciences. 2026. doi:10.1177/09727531261448654

BibTeX
@article{Dharwadkar2026,
  author = {Dharwadkar, Jahnavi and Nayak, Amrutha R and Rao, B S Shankaranarayana and Srikumar, Bettadapura N},
  title = {Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex},
  journal = {Annals of Neurosciences},
  year = {2026},
  doi = {10.1177/09727531261448654}
}
Kostenlos starten →